155 related articles for article (PubMed ID: 29548526)
1. Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study.
Mollard LM; Le Mao R; Tromeur C; Le Moigne E; Gouillou M; Pan-Petesch B; Delluc A; Couturaud F; Lacut K
Eur J Intern Med; 2018 Jun; 52():22-27. PubMed ID: 29548526
[TBL] [Abstract][Full Text] [Related]
2. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
[TBL] [Abstract][Full Text] [Related]
3. Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case-control study.
Martinez C; Katholing A; Folkerts K; Cohen AT
J Thromb Haemost; 2016 Jul; 14(7):1374-83. PubMed ID: 27079164
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Antipsychotic Treatment on Recurrent Venous Thromboembolic Disease: A Cohort Study.
Ferraris A; Szmulewicz AG; Posadas-Martínez ML; Serena MA; Vazquez FJ; Angriman F
J Clin Psychiatry; 2019 Aug; 80(5):. PubMed ID: 31509358
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Cancer after a Second Unprovoked Venous Thromboembolic Event.
Rézig S; Mao RL; Couturaud F; Lacut K; Delluc A
Thromb Haemost; 2019 Mar; 119(3):490-495. PubMed ID: 30685873
[TBL] [Abstract][Full Text] [Related]
6. B blood group: A strong risk factor for venous thromboembolism recurrence.
Baudouy D; Moceri P; Chiche O; Bouvier P; Schouver ED; Cerboni P; Gibelin P; Ferrari E
Thromb Res; 2015 Jul; 136(1):107-11. PubMed ID: 25981188
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
[TBL] [Abstract][Full Text] [Related]
8. Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study.
Le Mao R; Tromeur C; Bazire A; Gouillou M; Guegan M; Lacut K; Delluc A; Mottier D; Leroyer C; Couturaud F
Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28751412
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.
Larsen TB; Skjøth F; Kjældgaard JN; Lip GYH; Nielsen PB; Søgaard M
Lancet Haematol; 2017 May; 4(5):e237-e244. PubMed ID: 28411120
[TBL] [Abstract][Full Text] [Related]
10. Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case-control study.
Lacut K; Le Gal G; Couturaud F; Cornily G; Leroyer C; Mottier D; Oger E
Fundam Clin Pharmacol; 2007 Dec; 21(6):643-50. PubMed ID: 18034665
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD.
Ishiguro C; Wang X; Li L; Jick S
Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1168-75. PubMed ID: 25195779
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic drugs and venous thromboembolism.
Tromeur C; Couturaud F
Thromb Res; 2012 Oct; 130 Suppl 1():S29-31. PubMed ID: 23026655
[TBL] [Abstract][Full Text] [Related]
13. Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study.
Donadini MP; Dentali F; Pegoraro S; Pomero F; Brignone C; Guasti L; Steidl L; Ageno W
Vasc Med; 2017 Dec; 22(6):518-524. PubMed ID: 28732457
[TBL] [Abstract][Full Text] [Related]
14. Lipid lowering drugs and the risk of recurrent venous thromboembolism.
Delluc A; Tromeur C; Le Moigne E; Nowak E; Mottier D; Le Gal G; Lacut K
Thromb Res; 2012 Dec; 130(6):859-63. PubMed ID: 22939687
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from a long-term follow-up study.
Zhang S; Zhai Z; Yang Y; Zhu J; Kuang T; Xie W; Yang S; Liu F; Gong J; Shen YH; Wang C
Int J Cardiol; 2016 Jan; 202():275-81. PubMed ID: 26408837
[TBL] [Abstract][Full Text] [Related]
16. High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism.
Whitworth H; Clark HH; Hubbard RA; Witmer C; Leonard CE; Raffini L
J Thromb Haemost; 2023 Jan; 21(1):47-56. PubMed ID: 36695395
[TBL] [Abstract][Full Text] [Related]
17. A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES).
Franco Moreno AI; García Navarro MJ; Ortiz Sánchez J; Martín Díaz RM; Madroñal Cerezo E; de Ancos Aracil CL; Cabello Clotet N; Perales Fraile I; Gimeno García S; Montero Hernández C; Zapatero Gaviria A; Ruiz Giardín JM
Eur J Intern Med; 2016 Apr; 29():59-64. PubMed ID: 26775136
[TBL] [Abstract][Full Text] [Related]
18. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study.
Di Minno MN; Dentali F; Lupoli R; Ageno W
Circulation; 2014 Jan; 129(4):497-503. PubMed ID: 24146249
[TBL] [Abstract][Full Text] [Related]
19. Assessing the Rate of Antipsychotic Use in Ambulatory Care Patients With a Venous Thromboembolism.
Rarrick C; Saccone N; Hebbard A; Jones B
Ann Pharmacother; 2020 Feb; 54(2):97-104. PubMed ID: 31416330
[No Abstract] [Full Text] [Related]
20. Antipsychotic treatment and the occurrence of venous thromboembolism: a 10-year nationwide registry study.
Wu CS; Lin CC; Chang CM; Wu KY; Liang HY; Huang YW; Tsai HJ
J Clin Psychiatry; 2013 Sep; 74(9):918-24. PubMed ID: 24107765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
